Circumvent the Tariff challenges with an agile supply chain Consulting
Supply Chain Ecosystem Analysis now part of DBMR Reports
Global Nuclear Medicine Equipment Market
Market Size in USD Billion
CAGR :
%
USD
2.76 Billion
USD
4.64 Billion
2024
2032
Forecast Period
2025 –2032
Market Size(Base Year)
USD
2.76 Billion
Market Size (Forecast Year)
USD
4.64 Billion
CAGR
%
Major Markets Players
CMR Naviscan
Mallinckrodt Company
Neusoft Corporation
DDD-Diagnostic A/S
CANON MEDICAL SYSTEMS CORPORATION
Global Nuclear Medicine Equipment Market Segmentation, By Product Type (Single Photon-Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and Planar Scintigraphy), Application (Cardiology, Oncology, Neurology, General Imaging, and Others), End User (Hospitals, Imaging Centers, Academic and Research Centers, and Others) - Industry Trends and Forecast to 2032
Nuclear Medicine Equipment Market Size
The global nuclear medicine equipment market size was valued at USD 2.76 billion in 2024 and is expected to reach USD 4.64 billion by 2032,at a CAGR of 6.70% during the forecast period
This growth is driven by factors such as the advancements in technology, increasing applications in oncology, cardiology, and neurology, and the rising demand for early diagnosis and personalized treatment options
Nuclear Medicine Equipment Market Analysis
Nuclear medicine equipment is essential for diagnosing and treating various diseases, utilizing small amounts of radioactive materials for imaging and therapeutic procedures, such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT) scans
The demand for nuclear medicine equipment is primarily driven by advancements in imaging technologies, increasing cancer and cardiovascular disease prevalence, and the growing need for early diagnosis and precision medicine
North America is expected to dominate the nuclear medicine equipment market with a market share of 35.5%, due to advanced healthcare infrastructure, high adoption of cutting-edge imaging technologies, and a strong presence of leading manufacturers
Asia-Pacific is expected to be the fastest growing region in the nuclear medicine equipment market with a market share of 20.5%, during the forecast period due to rapid advancements in healthcare infrastructure, increasing awareness of early diagnosis, and growing surgical volumes
Single photon emission computed tomography (SPECT) segment is expected to dominate the market with a market share of 58.38% due to its cost-effectiveness, wide availability, and established clinical use. SPECT offers high-resolution imaging for a variety of conditions, including cardiovascular diseases, cancer, and neurological disorders
Report Scope and Nuclear Medicine Equipment Market Segmentation
Attributes
Nuclear Medicine Equipment Key Market Insights
Segments Covered
By Product Type: Single Photon-Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and Planar Scintigraphy
By Application: Cardiology, Oncology, Neurology, General Imaging, and Others
By End User: Hospitals, Imaging Centers, Academic and Research Centers, and Others
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include import export analysis, production capacity overview, production consumption analysis, price trend analysis, climate change scenario, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework.
Nuclear Medicine Equipment Market Trends
“Advancements in Imaging Technologies & Precision Medicine for Early Diagnosis”
A key trend in the evolution of nuclear medicine equipment is the increasing adoption of advanced imaging technologies such as PET and SPECT, coupled with the growing focus on precision medicine
These innovations enhance diagnostic accuracy by providing high-resolution, molecular-level imaging, enabling early detection of diseases such as cancer, cardiovascular conditions, and neurological disorders
For instance, PET imaging systems are evolving with enhanced sensitivity and faster scanning times, improving the detection of small tumors and abnormal tissue
These advancements are revolutionizing early-stage disease diagnosis, personalized treatment planning, and therapy monitoring, thereby driving demand for more sophisticated nuclear medicine equipment with cutting-edge capabilities
Nuclear Medicine Equipment Market Dynamics
Driver
“Increasing Demand Due to Rising Prevalence of Chronic Disease”
The growing prevalence of chronic diseases, particularly cancer, cardiovascular diseases, and neurological disorders, is significantly driving the demand for nuclear medicine equipment
As the global population ages and lifestyle-related diseases increase, the need for advanced diagnostic imaging technologies, such as PET and SPECT, has surged. These technologies are essential for early detection, precise diagnosis, and effective treatment planning
As more patients seek accurate and personalized treatments, the demand for nuclear medicine equipment rises, enhancing diagnostic capabilities and improving patient outcomes
For instance,
According to the World Health Organization, in 2021, cancer was one of the leading causes of death worldwide, contributing to an increased need for advanced imaging technologies to aid in early detection and staging of the disease
As a result, the rising prevalence of chronic diseases such as cancer, cardiovascular conditions, and neurological disorders is fueling the demand for nuclear medicine equipment, particularly for early diagnosis and personalized treatment approaches
Opportunity
“Advancing Imaging with Artificial Intelligence Integration”
AI-powered nuclear medicine imaging systems are poised to enhance diagnostic capabilities by improving image quality, automating analysis, and providing real-time insights for better decision-making in clinical settings
AI algorithms can analyze PET and SPECT images to detect abnormalities such as tumors, plaques, and other tissue irregularities with greater precision and speed, helping healthcare professionals identify potential issues early
Moreover, AI integration can assist in automating the image interpretation process, improving consistency and accuracy while reducing the workload of medical professionals, allowing them to focus on patient care
For instance,
In December 2024, according to an article published in The Lancet, AI models based on deep learning showed promise in analyzing PET scans for early-stage cancer detection, helping oncologists plan personalized treatment strategies based on precise, real-time data
The integration of AI in nuclear medicine imaging systems can lead to more accurate diagnostics, improved patient outcomes, and optimized treatment planning, ultimately enhancing the efficiency of the healthcare system and contributing to better disease management
The high cost of nuclear medicine equipment, particularly PET and SPECT scanners, remains a significant challenge for market growth, especially in low- and middle-income countries
These advanced imaging systems, which are critical for diagnosing complex conditions such as cancer and cardiovascular diseases, can cost millions of dollars, making them inaccessible for many healthcare facilities, especially smaller hospitals and clinics
This substantial financial burden associated with the purchase and maintenance of such equipment can prevent healthcare institutions from adopting newer technologies, leading to a reliance on older, less effective diagnostic tools
For instance,
In October 2024, according to an article published by the Journal of Nuclear Medicine, the high cost of PET and SPECT scanners continues to be a major barrier for healthcare systems in developing countries, limiting the widespread availability of nuclear medicine services and hindering access to cutting-edge diagnostic procedures
Consequently, these financial constraints can lead to disparities in the quality of healthcare, limit access to advanced diagnostic technologies, and ultimately slow the overall adoption and expansion of nuclear medicine equipment in global markets
Nuclear Medicine Equipment Market Scope
The market is segmented on the basis of product type, application, and end user
Segmentation
Sub-Segmentation
By Product Type
Single Photon-Emission Computed Tomography (SPECT)
Standalone
Hybrid
Positron Emission Tomography (PET)
Standalone
Hybrid
Planar Scintigraphy
By Application
Cardiology
Oncology
Neurology
General Imaging
Others
Urology
Gastroenterology
Orthopedics
By End User
Hospitals
Imaging Centers
Academic and Research Centers
Others
In 2025, the single photon emission computed tomography (SPECT) is projected to dominate the market with a largest share in product type segment
The single photon emission computed tomography (SPECT) segment is expected to dominate the nuclear medicine equipment market with the largest share of 58.38% in 2025due to its cost-effectiveness, wide availability, and established clinical use. SPECT offers high-resolution imaging for a variety of conditions, including cardiovascular diseases, cancer, and neurological disorders. Its versatility and ability to provide detailed functional information about organs contribute to its continued demand in diagnostic imaging
The oncology is expected to account for the largest share during the forecast period in application market
In 2025, the oncology segment is expected to dominate the market with the largest market share of 49.49% due to the increasing prevalence of cancer and the growing demand for early detection and precise treatment planning. Nuclear medicine technologies, such as PET and SPECT, offer detailed imaging that helps in tumor detection, staging, and monitoring therapy responses. These advancements are critical for improving patient outcomes and driving the adoption of nuclear imaging in oncology
Nuclear Medicine Equipment Market Regional Analysis
“North America Holds the Largest Share in the Nuclear Medicine Equipment Market”
North America dominates the nuclear medicine equipment market with a market share of estimated 35.5%, driven by advanced healthcare infrastructure, high adoption of cutting-edge imaging technologies, and a strong presence of leading manufacturers
U.S. holds a market share of 40.5%, due to high demand for early-stage disease detection, particularly for oncology, cardiovascular diseases, and neurological disorders, along with continuous advancements in nuclear imaging technologies such as PET and SPECT
The presence of well-established reimbursement policies, robust healthcare funding, and substantial investments in research and development by major medical device companies further strengthen the market position in this region
In addition, the increasing number of diagnostic procedures, combined with rising demand for personalized medicine and precision diagnostics, is driving market growth across North America.
“Asia-Pacific is Projected to Register the Highest CAGR in the Nuclear Medicine Equipment Market”
Asia-Pacific is expected to witness the highest growth rate in the nuclear medicine equipment market with a market share of 20.5%, driven by rapid advancements in healthcare infrastructure, increasing awareness of early diagnosis, and growing surgical volumes
Countries such as China, India, and Japan are emerging as key markets, with a large patient pool suffering from chronic diseases such as cancer, cardiovascular diseases, and neurological disorders. The rising demand for advanced diagnostic tools is contributing to significant market expansion
Japan, with its technological advancements in medical imaging and a well-established healthcare system, continues to lead in the adoption of nuclear medicine equipment, particularly in the areas of oncology and cardiology
India is projected to experience the highest CAGR in the nuclear medicine equipment market, fueled by expanding healthcare infrastructure, an increasing patient base for chronic diseases, and growing investments in advanced diagnostic technologies
Nuclear Medicine Equipment Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
The Major Market Leaders Operating in the Market Are:
Latest Developments in Global Nuclear Medicine Equipment Market
In December 2024, Canon Medical Systems announced new enhancements to its Celesteion PET/CT system, including advanced acquisition and reconstruction techniques. These improvements aim to deliver faster and more accurate imaging for oncology and cardiology applications
In May 2023, Koninklijke Philips N.V., Elekta, and Mercurius Health announced a 3-year agreement to equip Mercurius Health’s Robert Janker Klinik cancer center in Bonn, Germany. Philips and Elekta will install advanced oncology diagnostic and therapeutic equipment, along with aligned informatics solutions, enhancing cancer care capabilities at the newly acquired facility
In April 2022, Mediso Ltd. acquired Bartec Technologies Ltd., a UK-based company specializing in Nuclear Medicine and Molecular Imaging equipment. This acquisition aims to bolster Mediso’s presence in the UK and Ireland markets, leveraging Bartec’s expertise in supply, installation, and support of medical imaging technologies
In June 2022, Siemens Healthineers launched the Symbia Pro.specta, a SPECT/CT system with CE mark and FDA clearance. This advanced system integrates state-of-the-art SPECT and CT imaging technologies, featuring a low-dose CT capable of capturing detailed images with up to 64 slices, enhancing diagnostic accuracy and patient care
In November 2022, Canon, Inc. announced the establishment of Canon Healthcare USA, INC., a new subsidiary aimed at expanding Canon’s footprint in the American medical market. This strategic move underscores Canon’s commitment to advancing its medical business through enhanced service offerings and innovative healthcare solutions in the U.S.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
Interactive Data Analysis Dashboard
Company Analysis Dashboard for high growth potential opportunities
Research Analyst Access for customization & queries
Competitor Analysis with Interactive dashboard
Latest News, Updates & Trend analysis
Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
Claudio Rondena
Group Business Development & Strategic Marketing Director, C.O.C Farmaceutici SRL
"This morning we were involved in the first part, the data presentation of MKT analysis, selected abstract from your work. The board team was really impressed and very appreciated, as well."
David Manning - Thermo Fisher Scientific
Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice.
Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough.
Your work is much appreciated.
Manager - Market Analytics,
Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Business Development Manager,
(Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Business Intelligence and Analytics,
Ipsen Biopharm Limited
We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.
Competition Analyst,
Basler Web
I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.
Marketing Director,
Buhler Group
It was indeed a good experience, would definitely recommend and come back for future prospects.
COO,
A global leader providing Drug Delivery Services
DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.
Marketing Director,
Philips Healthcare
The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.
Product manager,
Fujifilms
Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.
Investor relations,
GE Healthcare
Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.
Market Analyst,
Medincell
We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.
Andrew - Senior Global Marketing Manager,
Medtronic (US)
I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.
Amarildo - Manager, Global Strategic Alignment
MasterCard
We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.
Tor Hammer
Green Nexus LLc
Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects
I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying.
Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.
Yuki Kopyl (Asian Business Development Department)
UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)
Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future
